Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 2, 2013, Pages 191-197

  Jalalian, Seyed Hamid ^a   Taghdisi, Seyed Mohammad ^b   Hamedani, Nasim Shahidi ^c   Kalat, Seyedeh Alia Moosavian ^c   Lavaee, Parirokh ^d   ZandKarimi, Majid ^b   Ghows, Narjes ^d   Jaafari, Mahmoud Reza ^c   Naghibi, Saeed ^e   Danesh, Noor Mohammad ^f   Ramezani, Mohammad ^c   Abnous, Khalil ^g  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f Khavaran Institute of Science and Technology   (Iran)

^g MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aptamer; Colon cancer; Epirubicin; MRI; SPION

Indexed keywords

APTAMER; EPIRUBICIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL VIABILITY; COLON CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG EFFICACY; FLOW CYTOMETRY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

APTAMER; COLON CANCER; EPIRUBICIN; MRI; SPION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; CHO CELLS; COLONIC NEOPLASMS; CRICETINAE; CRICETULUS; DIAGNOSTIC IMAGING; EPIRUBICIN; FERRIC COMPOUNDS; HUMANS; MAGNETIC PHENOMENA; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MUCIN-1; NANOPARTICLES;

EID: 84881151187     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.06.015     Document Type: Article

References (36)

1. Bagalkot, V., Farokhzad, O.C., Langer, R., Jon, S., 2006. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angewandte Chemie-International Edition 45, 8149-8152. (Pubitemid 44974149)
2. Bellah, M.M., Christensen, S.M., Iqbal, S.M., 2012. Nanostructures for medical diagnostics. Journal of Nanomaterials 2012.
3. Betancourt, T., Brown, B., Brannon-Peppas, L., 2007. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine 2, 219-232. (Pubitemid 46845768)
4. Blank, M., Blind, M., 2005. Aptamers as tools for target validation. Current Opinion in Chemical Biology 9, 336-342. (Pubitemid 41019677)
5. Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G.C.L., Cheng, J., Lu, Y., 2009. Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angewandte Chemie-International Edition 48, 6494-6498.
6. Cerchia, L., Duconge, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., De Franciscis, V., Libri, D., 2005. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biology 3, 0697-0704. (Pubitemid 40721162)
7. Chang, Y.J., Huang, Y.P., Li, Z.L., Chen, C.H., 2012. GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS ONE 7.
8. Clarke, S.J., Karapetis, C.S., Gibbs, P., Pavlakis, N., Desai, J., Michael, M., Tebbutt, N.C., Price, T.J., Tabernero, J., 2013. Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors. Critical Reviews in Oncology/Hematology 85, 121-135.
9. Davis, K.A., Lin, Y., Abrams, B., Jayasena, S.D., 1998. Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Research 26, 3915-3924. (Pubitemid 28401340)
10. Delfaut, E.M., Beltran, J., Johnson, G., Rousseau, J., Marchandise, X., Cotten, A., 1999. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 19, 373-382.
11. Duan, S., Bleibel, W.K., Huang, R.S., Shukla, S.J., Wu, X., Badner, J.A., Dolan, M.E., 2007. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Research 67, 5425-5433. (Pubitemid 46997283)
12. Erdem, A., Ozsoz, M., 2001. Interaction of the anticancer drug epirubicin with DNA. Analytica Chimica Acta 437, 107-114. (Pubitemid 32523002)
13. Ferreira, C.S.M., Cheung, M.C., Missailidis, S., Bisland, S., Gariépy, J., 2009. Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Research 37, 866-876.
14. Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., Chen, H., 2011. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32, 8010-8020.
15. Huang, Y.F., Shangguan, D., Liu, H., Phillips, J.A., Zhang, X., Chen, Y., Tan, W., 2009. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chem Bio Chem 10, 862-868.
16. Jain, K.K., 2005. Editorial: targeted drug delivery for cancer. Technology in Cancer Research and Treatment 4, 311-313. (Pubitemid 41242607)
17. Lee, H., Mi, K.Y., Park, S., Moon, S., Jung, J.M., Yong, Y.J., Kang, H.W., Jon, S., 2007. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. Journal of the American Chemical Society 129, 12739-12745. (Pubitemid 350004485)
18. Levy-Nissenbaum, E., Radovic-Moreno, A.F., Wang, A.Z., Langer, R., Farokhzad, O.C., 2008. Nanotechnology and aptamers: applications in drug delivery. Trends in Biotechnology 26, 442-449.
19. Li, D.C., Zhong, X.K., Zeng, Z.P., Jiang, J.G., Li, L., Zhao, M.M., Yang, X.Q., Chen, J., Zhang, B.S., Zhao, Q.Z., Xie, M.Y., Xiong, H., Deng, Z.Y., Zhang, X.M., Xu, S.Y., Gao, Y.X., 2009. Application of targeted drug delivery system in Chinese medicine. Journal of Controlled Release.
20. Meseguer, M., Pellicer, A., Simón, C., 1998. MUC1 and endometrial receptivity. Molecular Human Reproduction 4, 1089-1098. (Pubitemid 28552791)
21. Mojzisova, G., Mirossay, L., Kucerova, D., Kyselovic, J., Mirossay, A., Mojiz, J., 2006. Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity. Phytotherapy Research 20, 110-114. (Pubitemid 43266834)
22. Patel, S.G., Ahnen, D.J., 2012. Familial colon cancer syndromes: an update of a rapidly evolving field. Current Gastroenterology Reports 14, 428-438.
23. Que-Gewirth, N.S., Sullenger, B.A., 2007. Gene therapy progress and prospects: RNA aptamers. Gene Therapy 14, 283-291. (Pubitemid 46231922)
24. Ray, P., White, R.R., 2010. Aptamers for targeted drug delivery. Pharmaceuticals 3, 1761-1778.
25. Stoltenburg, R., Reinemann, C., Strehlitz, B., 2007. SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomolecular Engineering 24, 381-403. (Pubitemid 47391579)
26. Taghdisi, S.M., Abnous, K., Mosaffa, F., Behravan, J., 2010. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer. Journal of Drug Targeting 18, 277-281.
27. Taghdisi, S.M., Lavaee, P., Ramezani, M., Abnous, K., 2011. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes. European Journal of Pharmaceutics and Biopharmaceutics 77, 200-206.
28. Vasir, J.K., Labhasetwar, V., 2005. Targeted drug delivery in cancer therapy. Technology in Cancer Research and Treatment 4, 363-374. (Pubitemid 41242611)
29. Wang, Y.X.J., Hussain, S.M., Krestin, G.P., 2001. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. European Radiology 11, 2319-2331. (Pubitemid 33041104)
30. Wang, A.Z., Bagalkot, V., Vasilliou, C.C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M.J., Langer, R., Kantoff, P.W., Bander, N.H., Jon, S., Farokhzad, O.C., 2008. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chem Med Chem 3, 1311-1315.
31. Weissleder, R., 2006. Molecular imaging in cancer. Science 312, 1168-1171. (Pubitemid 43801133)
32. Ye, X., Yang, D., 2009. Recent advances in biological strategies for targeted drug delivery. Cardiovascular and Hematological Disorders-Drug Targets 9, 206-221.
33. Yu, M.K., Jeong, Y.Y., Park, J., Park, S., Kim, J.W., Min, J.J., Kim, K., Jon, S., 2008. Drugloaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angewandte Chemie-International Edition 47, 5362-5365.
34. Yusoff, H.M., Daud, N., Noor, N.M., Rahim, A.A., 2012. Participation and barriers to colorectal cancer screening in Malaysia. Asian Pacific Journal of Cancer Prevention 13, 3983-3987.
35. Zhu, L., Huo, Z., Wang, L., Tong, X., Xiao, Y., Ni, K., 2009. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. International Journal of Pharmaceutics 370, 136-143.
36. Zuker, M., 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research 31, 3406-3415. (Pubitemid 37442169)